![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 207/08 | (2006.01) |
A61K 31/40 | (2006.01) | ||
A61P 25/32 | (2006.01) |
(11) | Number of the document | 2252581 |
(13) | Kind of document | T |
(96) | European patent application number | 09703808.7 |
Date of filing the European patent application | 2009-01-13 | |
(97) | Date of publication of the European application | 2010-11-24 |
(45) | Date of publication and mention of the grant of the patent | 2012-06-20 |
(46) | Date of publication of the claims translation | 2012-09-25 |
(86) | Number | PCT/US2009/030811 |
Date | 2009-01-13 |
(87) | Number | WO 2009/094260 |
Date | 2009-07-30 |
(30) | Number | Date | Country code |
08380012 | 2008-01-22 | EP | |
39121 P | 2008-03-25 | US |
(72) |
DIAZ BUEZO, Nuria, ES
MCKINZIE, David, Lee, US
MITCH, Charles, Howard, US
PEDREGAL-TERCERO, Concepcion, ES
|
(73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
(74) |
Jelena GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Kapa selektyvus opioido receptoriaus antagonistas |
KAPPA SELECTIVE OPIOID RECEPTOR ANTAGONIST |
Payment date | Validity (years) | Amount | |
2024-12-03 | 17 | 347.00 EUR |
2026-01-13 |